SATSUMA PHARMACEUTICALS, INC. (STSA): Price and Financial Metrics
STSA Price/Volume Stats
| Current price | $1.10 | 52-week high | $8.08 |
| Prev. close | $1.11 | 52-week low | $0.59 |
| Day low | $1.01 | Volume | 1,829,700 |
| Day high | $1.14 | Avg. volume | 701,788 |
| 50-day MA | $0.97 | Dividend yield | N/A |
| 200-day MA | $2.38 | Market Cap | 36.47M |
STSA Stock Price Chart Interactive Chart >
SATSUMA PHARMACEUTICALS, INC. (STSA) Company Bio
Satsuma Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It develops novel therapeutic products for the acute treatment of migraine. The company was founded by John Kollins on June 21, 2016 and is headquartered in San Francisco, CA.
STSA Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -76.24% |
| 5-year | -93.91% |
| YTD | N/A |
| 2023 | 0.00% |
| 2022 | -80.00% |
| 2021 | -2.39% |
| 2020 | -76.58% |
| 2019 | N/A |
Loading social stream, please wait...